论文部分内容阅读
我国胃肠道肿瘤的发病率和死亡率都很高,手术切除是首选治疗方法,但术后局部复发和远处转移率可高达到37％～50％,肿瘤一旦浸润至浆膜,腹膜种植转移的发生率可达28.6％.当浆膜浸润面积超过15～20mm2时几乎所有的胃癌患者腹腔内均可检到肿瘤细胞。胃肠道肿瘤腹膜转移后,肠梗阻和腹腔积液等并发症可相继出现,严重影响患者的生活质量和预后,所以胃肠道肿瘤蝮膜转移的治疗是临床上急需解决的问题。由于胃肠道肿瘤腹腔内化疗(In—traperitoneal Chemotherapy,IPCT)直接作用于腹膜,对防治胃
Gastrointestinal cancer incidence and mortality in China are high, surgical removal is the preferred treatment, but the local recurrence and distant metastasis rate can be as high as 37% to 50%, once the tumor infiltrated into the serosa, peritoneal planting The incidence of metastasis up to 28.6%. When the area of serosal invasion more than 15 ~ 20mm2 when almost all gastric cancer patients can be detected intraperitoneally tumor cells. Gastrointestinal cancer peritoneal metastasis, intestinal obstruction and ascites and other complications can occur one after another, seriously affecting the quality of life and prognosis of patients, so the treatment of gastrointestinal tumor gallbladder membrane metastasis is a clinically urgent problem to be solved. As gastrointestinal cancer intraperitoneal chemotherapy (In-traperitoneal Chemotherapy, IPCT) directly on the peritoneum, the prevention and treatment of stomach